Run Zheng

Title: The Innovative Contributions of Run Zheng in Colorectal Cancer Detection

Introduction

Run Zheng is a notable inventor based in Richmond Hill, Canada, recognized for his significant contributions to the field of colorectal cancer detection. With a total of two patents, Zheng's work focuses on innovative methods and systems that enhance the accuracy of testing for colorectal pathologies, including cancer.

Latest Patents

Run Zheng's latest patents involve groundbreaking methodologies in the detection of colorectal cancer. The first patent details a method, computer-readable medium, and system designed to determine the probability of colorectal cancer in a test subject. This innovation provides a method of testing by using data corresponding to levels of selected biomarkers and applying this data to a formula. This formula serves as an indicator of whether the test subject has colorectal cancer. Additionally, the patent includes kits for measuring the biomarkers and methods for monitoring the efficacy of therapeutic treatments for colorectal cancer.

The second patent expands on the same theme, presenting a similar method to ascertain one or more colorectal pathologies or subtypes of colorectal pathology, including colorectal cancer. This method emphasizes a computer-based approach, where the computer analyzes the data and provides indications of possible pathologies. Like the first patent, it encompasses kits for measuring relevant biomarkers and therapeutic efficacy monitoring.

Career Highlights

Run Zheng is affiliated with GeneNews Corporation, an organization dedicated to advancing cancer diagnostics. His role at this innovative company exemplifies his commitment to improving healthcare outcomes through technology-driven solutions. Zheng's contributions to the company and the medical field highlight his dedication to research and innovation.

Collaborations

Throughout his career, Run Zheng has collaborated with esteemed colleagues such as Choong-Chin Liew and Mark Han. These partnerships have not only fostered a rich environment for innovation but also contributed to the development of significant medical breakthroughs in cancer diagnostics.

Conclusion

Run Zheng's work has played a crucial role in the advancement of colorectal cancer detection methodologies. His innovative patents and collaborative efforts at GeneNews Corporation underscore his dedication to enhancing medical diagnostics and improving patient outcomes. As the medical community continues to grapple with cancer detection, the contributions of inventors like Run Zheng remain invaluable.